Jesse D. Bloom

Active 2001–2025

Also published as
Jesse D Bloom
168
Papers
28,396
Citations
83
h-index
157
i10-index

Citations

Citations per year for Jesse D. Bloom1990: 1 citations1995: 1 citations1997: 1 citations1998: 2 citations1999: 6 citations2001: 1 citations2002: 3 citations2003: 5 citations2004: 16 citations2005: 30 citations2006: 67 citations2007: 77 citations2008: 81 citations2009: 103 citations2010: 120 citations2011: 96 citations2012: 119 citations2013: 92 citations2014: 152 citations2015: 129 citations2016: 131 citations2017: 158 citations2018: 223 citations2019: 471 citations2020: 730 citations2021: 2,384 citations2022: 1,770 citations2023: 1,052 citations2024: 1,344 citations2025: 652 citations2026: 32 citations1991–1994: no citations, so these years are not shown1996: no citations, so this year is not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,254 citing papers, 32% of this breakdownUnited Kingdom: 785 citing papers, 7.7% of this breakdownChina: 783 citing papers, 7.7% of this breakdownGermany: 499 citing papers, 4.9% of this breakdownCanada: 328 citing papers, 3.2% of this breakdownSwitzerland: 304 citing papers, 3% of this breakdownFrance: 297 citing papers, 2.9% of this breakdownAustralia: 286 citing papers, 2.8% of this breakdownItaly: 231 citing papers, 2.3% of this breakdownNetherlands: 227 citing papers, 2.2% of this breakdownSpain: 222 citing papers, 2.2% of this breakdownJapan: 217 citing papers, 2.2% of this breakdown
0%32%Other 26.9%

Fields

  • Medicine60.3%
  • Biochemistry, Genetics and Molecular Biology27.2%
  • Immunology and Microbiology4.5%
  • Agricultural and Biological Sciences1.5%
  • Environmental Science1.1%
  • Computer Science0.9%
  • Other4.5%

Topics

  • SARS-CoV-2 and COVID-19 Research15.7%
  • COVID-19 Clinical Research Studies6.5%
  • vaccines and immunoinformatics approaches3.7%
  • Influenza Virus Research Studies3.7%
  • SARS-CoV-2 detection and testing3.3%
  • Animal Virus Infections Studies3%
  • Other64.1%

Coauthors

All papers

Open in search
  1. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

    Authors: , , , , , , , , , , , , - Cell 2020 cited by 2,263

  2. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria L. Agostini, Nicole Sprugasci, Katja Culap, Stefano Jaconi, Marcel Meury, Exequiel Dellota, Rana Abdelnabi, Caroline S. Foo, Elisabetta Cameroni, Spencer Stumpf, Tristan I. Croll, Jay C. Nix, Colin Havenar‐Daughton, Luca Piccoli, Fabio Benigni, Johan Neyts, Amalio Telenti, Florian A. Lempp, Matteo Samuele Pizzuto, John D. Chodera, Christy M. Hebner, Herbert W. Virgin, Sean P. J. Whelan, David Veesler, Davide Corti, Jesse D. Bloom, Gyorgy Snell - Nature 2021 cited by 600

  3. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike

    Authors: , , , , , , , , , , , , , - Cell 2023 cited by 214

  4. Protein stability promotes evolvability

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 1,256

  5. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 283

  6. Molecular fate-mapping of serum antibody responses to repeat immunization

    Authors: , , , , , , , , , , , , - Nature 2023 cited by 180

  7. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

    Authors: , , , , , , - Cell Host & Microbe 2021 cited by 1,314

  8. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 479

  9. ACE2 binding is an ancestral and evolvable trait of sarbecoviruses

    Authors: , , , , , , - Nature 2022 cited by 231

  10. Spike deep mutational scanning helps predict success of SARS-CoV-2 clades

    Authors: , , , , , , , , , , , , , - Nature 2024 cited by 128

  11. Broadly neutralizing antibodies target a haemagglutinin anchor epitope

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynda Coughlan, Andrew B. Ward, Patrick C. Wilson - Nature 2021 cited by 190

  12. Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1

    Authors: , , , , , , , , , - Nature Communications 2022 cited by 174

  13. Broad sarbecovirus neutralization by a human monoclonal antibody

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiara Silacci Fregni, Rana Abdelnabi, Caroline S. Foo, Colin Havenar‐Daughton, Michael Schmid, Fabio Benigni, Elisabetta Cameroni, Johan Neyts, Amalio Telenti, Herbert W. Virgin, Sean P. J. Whelan, Gyorgy Snell, Jesse D. Bloom, Davide Corti, David Veesler, Matteo Samuele Pizzuto - Nature 2021 cited by 317

  14. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah R. Leist, David R. Martinez, Matthew Clark, Roland Tisch, Derek T. O’Hagan, Robbert van der Most, Wesley C. Van Voorhis, Davide Corti, Jason S. McLellan, Harry Kleanthous, Timothy P. Sheahan, Kelly D. Smith, Deborah H. Fuller, François Villinger, Jesse D. Bloom, Bali Pulendran, Ralph S. Baric, Neil P. King, David Veesler - Cell 2021 cited by 192

  15. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesse D. Bloom, James E. Crowe - Nature Microbiology 2021 cited by 330

  16. Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein

    Authors: , , , , , , , , , , , , , , , - Cell 2022 cited by 100

  17. A framework for exhaustively mapping functional missense variants

    Authors: , , , , , , , , , , , , , , , , , , , , - Molecular Systems Biology 2017 cited by 235

  18. Defining the risk of SARS-CoV-2 variants on immune protection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ali H. Ellebedy, Thomas Fabrizio, Guido Ferrari, Will Fischer, William C. Florence, Ron A. M. Fouchier, John Franks, Adolfo Garcı́a-Sastre, Adam Godzik, Ana S. Gonzalez‐Reiche, Aubree Gordon, Bart L. Haagmans, Peter Halfmann, David D. Ho, Michael R. Holbrook, Yaoxing Huang, Sarah L. James, Lukasz Jaroszewski, Trushar Jeevan, Robert M. Johnson, Terry C. Jones, Astha Joshi, Yoshihiro Kawaoka, Lisa Kercher, Marion Koopmans, Bette Korber, Eilay Koren, Richard A. Koup, Eric B. LeGresley, Jacob E. Lemieux, Mariel J. Liebeskind, Zhuoming Liu, Brandi Livingston, James Logue, Yang Luo, Adrian B. McDermott, Margaret Juliana McElrath, Victoria Meliopoulos, Vineet D. Menachery, David C. Montefiori, Barbara Mühlemann, Vincent J. Munster, Jenny Munt, Manoj S. Nair, Antonia Netzl, Anna Maria Niewiadomska, Sijy O’Dell, Andrew Pekosz, Stanley Perlman, Marjorie Cornejo Pontelli, Barry Rockx, Morgane Rolland, Paul W. Rothlauf, Sinai Sacharen, Richard H. Scheuermann, Stephen D. Schmidt, Michael Schotsaert, Stacey Schultz‐Cherry, Robert A. Seder, Mayya Sedova, Alessandro Sette, Reed S. Shabman, Xiaoying Shen, Pei‐Yong Shi, Maulik Shukla, Viviana Simon, Spencer Stumpf, Nancy J. Sullivan, Larissa B. Thackray, James Theiler and 30 more - Nature 2022 cited by 185

  19. Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 164

  20. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Griselda De Marco, María Loreto Ferrús, Sandra Carbó-Ramírez, Giuseppe D’Auria, Mireia Coscollá, Paula Ruiz-Rodríguez, Francisco Javier Roig-Sena, Isabel Sanmartín, Daniel García‐Souto, Ana Pequeño‐Valtierra, José M. C. Tubío, Jorge Rodríguez‐Castro, Núria Rabella, Ferrán Navarro, Elisenda Miró, Manuel Rodríguez‐Iglesias, Fátima Galán‐Sánchez, Salud Rodríguez-Pallares, María de Toro, María Pilar Bea-Escudero, José Manuel Azcona, Mirian Blasco Alberdi, Alfredo Mayor, Alberto L. García‐Basteiro, Gemma Moncunill, Carlota Dobaño, Pau Cisteró, Darı́o Garcı́a de Viedma, Laura Pérez-Lago, Marta Herránz, Jon Sicilia, Pilar Catalán-Alonso, Patricia Muñóz, Cristina Muñoz-Cuevas, Guadalupe Rodríguez-Rodríguez, Juan Alberola, José Miguel Nogueira, Juan J. Camarena, Antonio Rezusta, Alexander Tristancho-Baró, Ana Milagro, Nieves Felisa Martínez-Cameo, Yolanda Gracia-Grataloup, Elisa Martró, Antoni E. Bordoy, Anna Not, Adrián Antuori-Torres, Rafael Benito, Sonia Algarate, Jessica Bueno, José Luís del Pozo, José Antonio Boga, Cristian Castelló-Abiétar, Susana Rojo‐Alba, Marta Elena Álvarez‐Argüelles, Santiago Melón, Maitane Aranzamendi-Zaldumbide, Andrea Vergara-Gómez, Jovita Fernández-Piñero, Miguel J. Martínez, Jordi Vilà, Elisa Rubio-García, Aida Peiró-Mestres, Jessica Navero‐Castillejos, David Posada, Diana Valverde, Nuria Estévez‐Gómez, Iria Fernández-Silva, Loretta De Chiara, Pilar Gallego‐García and 94 more - Nature 2021 cited by 458

  21. Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 241

  22. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin

    Authors: , , - Nature Communications 2018 cited by 187

  23. Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance

    Authors: , , - Science 2010 cited by 704

  24. An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain

    Authors: , , - Virus Evolution 2022 cited by 168